alofisel
takeda pharma a/s - darvadstrocel - rektal fistel - immunosuppressiva - alofisel er indiceret til behandling af komplekse endetarmsåbning fistler hos voksne patienter med ikke-aktive/mildt aktiv luminal crohn ' s sygdom, når fistler har vist et utilstrækkeligt respons på mindst én konventionelle eller biologiske terapi. alofisel bør anvendes efter konditionering af fistler.
ultomiris
alexion europe sas - ravulizumab - hemoglobinuri, paroxysmal - selektive immunosuppressiva - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
tolucombi
krka, d.d., novo mesto - telmisartan, hydrochlorothiazide - forhøjet blodtryk - telmisartan og diuretika - tolucombi-fastdosis kombination (80 mg telmisartan / 25 mg hydrochlorthiazid) er indiceret hos voksne, hvis blodtryk ikke er tilstrækkeligt kontrolleret på tolucombi 80 mg / 12. 5 mg (80 mg telmisartan/12. 5 mg hydrochlorthiazid) eller voksne, som tidligere har været stabiliseret på telmisartan og hydrochlorthiazid givet separat.
dutch trig suspensionskoncentrat
idverde bomendienst b.v. (tidligere btl bomendienst b.v.) - verticillium - suspensionskoncentrat - 10000000 cfu/ml verticillium albo-atrum strain wcs850
agros florasulam + 2,4 d suspoemulsion
agros - florasulam, 2,4-d - suspoemulsion - 6,2 g/l florasulam ; 300 g/l 2,4-d
aerinaze
n.v. organon - desloratadine, pseudophedrine sulfate - rhinitis, allergisk, sæsonbestemt - nasale præparater - symptomatisk behandling af sæsonbetonet allergisk rhinitis, når den ledsages af næsestop.
furosemid "accord" 10 mg/ml injektions-/infusionsvæske, opløsning
accord healthcare b.v. - furosemid - injektions-/infusionsvæske, opløsning - 10 mg/ml
lfs florasulam 2,4-d flydende middel
lfs kemi - florasulam, 2,4-d - flydende middel - 6,2 g/l florasulam ; 300 g/l 2,4-d
nipruss 60 mg pulver til infusionsvæske, opløsning
Øresund pharma aps - natriumnitroprussiddihydrat - pulver til infusionsvæske, opløsning - 60 mg
actelsar hct
actavis group hf - telmisartan, hydrochlorothiazide - essential hypertension - agents acting on the renin-angiotensin system, angiotensin ii antagonists and diuretics - behandling af essentiel hypertension. actelsar hct faste dosiskombination (40 mg telmisartan / 12. 5 mg hydrochlorthiazid) er indiceret hos voksne, hvis blodtryk ikke er tilstrækkeligt kontrolleret på telmisartan alene. actelsar hct faste dosiskombination (80 mg telmisartan / 12. 5 mg hydrochlorthiazid) er indiceret hos voksne, hvis blodtryk ikke er tilstrækkeligt kontrolleret på telmisartan alene. actelsar hct faste dosiskombination (80 mg telmisartan / 25 mg hydrochlorthiazid) er indiceret hos voksne, hvis blodtryk ikke er tilstrækkeligt kontrolleret på actelsar hct 80 mg / 12. 5 mg (80 mg telmisartan / 12. 5 mg hydrochlorthiazid) eller voksne, som tidligere har været stabiliseret på telmisartan og hydrochlorthiazid givet separat.